Last updated on March 2018

Pediatric Peanut Allergy


Brief description of study

A randomized, double-blind, placebo-controlled, multi-center study to assess the safety, tolerability and immunologic effects of HAL-MPE1 subcutaneous immunotherapy in adult and pediatric subjects with peanut allergy.

Clinical Study Identifier: TX198894

Contact Investigators or Research Sites near you

Start Over

Cherish Semeski

Vital Prospects Clinical Research Institute, P.C.
Tulsa, OK USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.